(Q46884201)

26 December 2017

title

The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid (English)

1 reference

26 December 2017

0 references

3

1 reference

26 December 2017

author name string

Christopher Paul Desmond

1

1 reference

26 December 2017

John Wilson

2

1 reference

26 December 2017

Denise Clark

4

1 reference

26 December 2017

Stuart Keith Roberts

5

1 reference

26 December 2017

publication date

1 December 2007

1 reference

26 December 2017

published in

Liver International

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

10

1 reference

26 December 2017

page(s)

1402-1408

1 reference

26 December 2017

Cystic Fibrosis Adult Care

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

Cholangiocyte biology and cystic fibrosis liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

Clinical and genetic risk factors for cystic fibrosis-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

Genotype analysis for delta F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

The epidemiology of cancer therapy. II. The clinical course: data, decisions, and temporal demarcations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01570.X

10.1111/J.1478-3231.2007.01570.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017